|
[1]
|
Sahota, O. (2014) Understanding Vitamin D Deficiency. Age and Ageing, 43, 589-591.
[Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
McGrath, J.J., et al. (2010) A Systematic Review of the Association between Common Single Nucleotide Polymorphisms and 25-Hydroxyvitamin D Concentrations. The Journal of Steroid Biochemistry and Molecular Biology, 121, 471-477.
[Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Go, A.S., et al. (2014) Heart Disease and Stroke Statistics—2014 Update: A Report from the American Heart Association. Circulation, 129, e28-e292.
[Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Brondum-Jacobsen, P., et al. (2013) 25-Hydroxyvitamin D and Symptomatic Ischemic Stroke: An Original Study and Meta-Analysis. Annals of Neurology, 73, 38-47.
[Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Pilz, S., et al. (2011) Vitamin D Supplementation: A Promising Approach for the Prevention and Treatment of Strokes. Current Drug Targets, 12, 88-96.
[Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Sierra, C., Coca, A. and Schiffrin, E.L. (2011) Vascular Mechanisms in the Pathogenesis of Stroke. Current Hypertension Reports, 13, 200-207.
[Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Li, Y.C., et al. (2004) Vitamin D: A Negative Endocrine Regu-lator of the Renin-Angiotensin System and Blood Pressure. Journal of Steroid Biochemistry & Molecular Biology, 89-90, 387-392.
[Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ohsawa, M., et al. (2000) 1α,25-Dihydroxyvitamin D(3) and Its Potent Synthetic Analogs Downregulate Tissue Factor and Upregulate Thrombomodulin Expression in Monocytic Cells, Counteracting the Effects of Tumor Necrosis Factor and Oxidized LDL. Circulation, 102, 2867-2872.
[Google Scholar] [CrossRef]
|
|
[9]
|
Aihara, K., et al. (2004) Disruption of Nuclear Vitamin D Re-ceptor Gene Causes Enhanced Thrombogenicity in Mice. The Journal of Biological Chemistry, 279, 35798-35802.
[Google Scholar] [CrossRef]
|
|
[10]
|
Strawbridge, R.J., et al. (2014) A Serum 25-Hydroxyvitamin D Concentration-Associated Genetic Variant in DHCR7 Interacts with Type 2 Diabetes Status to Influence Subclinical Atherosclerosis (Measured by Carotid Intima-Media Thickness). Diabetologia, 57, 1159-1172.
|
|
[11]
|
Bobryshev, Y.V. (2010) Vitamin D3 Suppresses Immune Reactions in Atherosclerosis, Affecting Regulatory T Cells and Dendritic Cell Function. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 2317-2319.
[Google Scholar] [CrossRef]
|
|
[12]
|
Montine, T.J., et al. (2014) Recommendations of the Alz-heimer’s Disease-Related Dementias Conference. Neurology, 83, 851-860.
[Google Scholar] [CrossRef]
|
|
[13]
|
Querfurth, H.W. and LaFerla, F.M. (2010) Alzheimer’s Disease. The New England Journal of Medicine, 362, 329-344.
[Google Scholar] [CrossRef]
|
|
[14]
|
Afzal, S., Bojesen, S.E. and Nordestgaard, B.G. (2014) Reduced 25-Hydroxyvitamin D and Risk of Alzheimer’s Disease and Vascular Dementia. Alzheimer’s & Dementia, 10, 296-302.
[Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Annweiler, C., et al. (2012) Higher Vitamin D Dietary Intake Is Associated with Lower Risk of Alzheimer’s Disease: A 7-Year Follow-Up. Journals of Gerontology: Series A-Biological Sciences and Medical Sciences, 67, 1205-1211.
[Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Durk, M.R., et al. (2014) 1α,25-Dihydroxyvitamin D3 Reduces Cer-ebral Amyloid-Beta Accumulation and Improves Cognition in Mouse Models of Alzheimer’s Disease. Journal of Neuroscience, 34, 7091-7101.
[Google Scholar] [CrossRef]
|
|
[17]
|
Lemire, P., et al. (2018) Cognitive Changes under Me-mantine According to Vitamin D Status in Alzheimer Patients: An Exposed/Unexposed Cohort Pilot Study. The Journal of Steroid Biochemistry and Molecular Biology, 175, 151-156.
[Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Lương, K.V.O. and Nguyễn, L.T.H. (2013) The Role of vitamin D in Alzheimer’s Disease: Possible Genetic and Cell Signaling Mechanisms. American Journal of Alzheimer’s Disease & Other Dementias, 28, 126-136.
[Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Moore, M.E., et al. (2005) Evidence That Vitamin D3 Reverses Age-Related Inflammatory Changes in the Rat Hippocampus. Biochemical Society Transactions, 33, 573-577.
[Google Scholar] [CrossRef]
|
|
[20]
|
Brown, J., et al. (2003) 1,25-Dihydroxyvitamin D3 Induces Nerve Growth Factor, Promotes Neurite Outgrowth and Inhibits Mitosis in Embryonic rat Hippocampal Neurons. Neuroscience Letters, 343, 139-143.
[Google Scholar] [CrossRef]
|
|
[21]
|
Wang, Y., et al. (2000) Vitamin D(3) Attenuates Cortical Infarction Induced by Middle Cerebral Arterial Ligation in Rats. Neuropharmacology, 39, 873-880.
[Google Scholar] [CrossRef]
|
|
[22]
|
Compston, A. and Coles, A. (2008) Multiple Sclerosis. The Lancet, 372, 1502-1517.
[Google Scholar] [CrossRef]
|
|
[23]
|
侯凡芳, 李豪杰. 血清中维生素D水平与多发性硬化关系的系统评价[J]. 中国药物与临床, 2015, 15(3): 312-315.
|
|
[24]
|
Yang, C.Y., et al. (2013) The Implication of Vitamin D and Autoimmunity: A Comprehensive Review. Clinical Reviews in Allergy & Immunology, 45, 217-226.
[Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Chang, J.H., et al. (2010) 1,25-Dihydroxyvitamin D3 Inhibits the Differentiation and Migration of T(H)17 Cells to Protect against Experimental Autoimmune Encephalomyelitis. PLoS ONE, 5, e12925.
[Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Joshi, S., et al. (2011) 1,25-Dihydroxyvitamin D(3) Amelio-rates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A. Molecular and Cellular Biology, 31, 3653-3669.
[Google Scholar] [CrossRef]
|
|
[27]
|
Li, C., et al. (2015) Vitamin D Receptor Gene Poly-morphisms and the Risk of Parkinson’s Disease. Neurological Sciences, 36, 247-255.
[Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Török, R., et al. (2013) Association of Vitamin D Receptor Gene Polymorphisms and Parkinson’s Disease in Hungarians. Neuroscience Letters, 551, 70-74.
[Google Scholar] [CrossRef] [PubMed]
|